Who are Moleculeralabs's investors?

Moleculeralabs's investors include Plains Ventures, Prolog Ventures.

Moleculeralabs

Founded 2011 · 14 employees on LinkedIn · 2 known investors

Find your way into Moleculeralabs

Moleculera Biosciences is a precision medicine company that develops blood-based immune-mediated autoantibody testing panels and AI-driven diagnostic tools to identify immune dysfunction underlying chronic neuropsychiatric and cardiovascular disorders, as well as Alzheimer's disease. The company operates an integrated platform combining diagnostic panels, a biorepository with bioinformatics, and a therapeutic target identification program.

AI & Machine Learning Biotech Digital Health Medical Devices

Investors · 2

Plains VenturesOklahoma City · $250K – $1M

Prolog VenturesClayton · $250K – $1M

Competitors · 1

by search overlap

Moleculera174 shared keywordsMoleculera Labs offers the Autoimmune Brain Panel, a diagnostic blood test that identifies autoimmune dysfunction in patients with treatment-resistant neuropsychiatric and behavioral symptoms. The test measures autoimmune antibodies targeting brain receptors to help clinicians distinguish autoimmune-driven conditions from primary psychiatric or neurologic disorders.

Companies competing with Moleculeralabs for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Moleculeralabs do?: Moleculera Biosciences is a precision medicine company that develops blood-based immune-mediated autoantibody testing panels and AI-driven diagnostic tools to identify immune dysfunction underlying chronic neuropsychiatric and cardiovascular disorders, as well as Alzheimer's disease. The company operates an integrated platform combining diagnostic panels, a biorepository with bioinformatics, and a therapeutic target identification program.
Who are Moleculeralabs's investors?: Moleculeralabs's investors include Plains Ventures, Prolog Ventures.